Table 1.
Demographic and clinical details of study participants.
| Demographic Details and Therapeutic Intervention | Arm-1 (n = 55) |
Arm-2 (n = 55) |
Arm-3 (n = 55) |
Overall (N = 165) |
|---|---|---|---|---|
| Age in years | ||||
| Mean Age ± SD | 38.2 ± 7.7 | 35.0 ± 8.7 | 38.7 ± 6.8 | 37.3 ± 7.9 |
| Gender | ||||
| Female | 39 (23.6) | 37 (22.4) | 41 (24.8) | 117 (70.9) |
| Male | 16 (9.6) | 18 (10.9) | 14 (8.4) | 48 (29.0) |
| Diagnosis | ||||
| Mild depression | 28 (16.9) | 25 (15.1) | 25 (15.1) | 78 (47.2) |
| Moderate depression | 27 (16.3) | 30 (18.1) | 30 (18.1) | 87 (52.7) |
| Treatment options | ||||
| Omega-3 fatty acid supplements, 500 mg daily. | 55 (33.3) | NA | 55 (33.3) | 110 (66.6) |
| Escitalopram, 10 mg, daily | NA | 18 (10.9) | 21 (12.7) | 39 (23.6) |
| Sertraline, 100 mg, daily | NA | 15 (9.0) | 11 (6.6) | 26 (15.7) |
| Fluoxetine, 20 mg, daily | NA | 22 (13.3) | 23 (13.9) | 45 (27.2) |